NOT-HL-18-637: Notice of NHLBI Participation in PA-18-837 "Administrative Supplements to Promote Diversity in Research and Development Small Business-SBIR/STTR (Admin Supp Clinical Trial Not Allowed)"

Notice of NHLBI Participation in PA-18-837 "Administrative Supplements to Promote Diversity in Research and Development Small Business-SBIR/STTR (Admin Supp Clinical Trial Not Allowed)"

Notice Number: NOT-HL-18-637

Key Dates
Release Date: June 28, 2018

Related Announcements
PA-18-837

Issued by
National Heart, Lung, and Blood Institute (NHLBI)

Purpose

The purpose of this Notice is to inform potential applicants that the National Heart, Lung, and Blood Institute (NHLBI) will participate, effective immediately, in PA-18-837 "Administrative Supplements to Promote Diversity in Research and Development Small Businesses-SBIR/STTR (Admin Supp Clinical Trial Not Allowed)" issued by the National Institutes of Health.

The following sections of PA-18-837 have been updated to reflect the participation of NHLBI in this Funding Opportunity Announcement (FOA):

Part 1. Overview Information

Components of Participating Organizations

National Cancer Institute (NCI)
National Eye Institute (NEI)
National Human Genome Research Institute (NHGRI)
National Institute on Aging (NIA)
National Institute on Alcohol Abuse and Alcoholism (NIAAA)
National Institute of Allergy and Infectious Diseases (NIAID)
National Institute of Biomedical Imaging and Bioengineering (NIBIB)
National Institute of Dental and Craniofacial Research (NIDCR)
National Institute on Drug Abuse (NIDA)
National Institute of General Medical Sciences (NIGMS)
National Institute of Neurological Disorders and Stroke (NINDS)
National Institute of Nursing Research (NINR)
National Institute on Minority Health and Health Disparities (NIMHD)
National Center for Complementary and Integrative Health (NCCIH)
National Center for Advancing Translational Sciences (NCATS)

National Heart, Lung, and Blood Institute (NHLBI)

Catalog of Federal Domestic Assistance (CFDA) Number(s)

93.273, 93.866, 93.855, 93.213, 93.394, 93.393, 93.395, 93.396, 93.399, 93.279, 93.121, 93.286, 93.867, 93.859, 93.172, 93.307, 93.361, 93.853, 93.350, 93.837, 93.838, 93.839, 93.840, 93.233

Section VII. Agency Contacts

Scientific/Research Contact(s)

Mike Pieck, Ph.D.
National Heart, Lung, and Blood Institute (NHLBI)
Office of Translational Alliances (OTAC)
Phone: 301-496-2149
Email: NHLBI_@[email protected]

Financial/Grants Management Contact(s)

Ms. Ann Marie Brasile Mejac, AA,CRA
National Heart, Lung, and Blood Institute (NHLBI)
Phone: 301-827-8016
Email: [email protected]

Ms. Leslie West-Bushby
National Heart, Lung, and Blood Institute (NHLBI)
Phone: 301-827-8063
Email: [email protected]

All other aspects of the FOA remain the same.

Inquiries

Please direct all inquiries to:

Scientific/Research Contact(s)

Mike Pieck, Ph.D.
National Heart, Lung, and Blood Institute (NHLBI)
Office of Translational Alliances (OTAC)
Phone: 301-496-2149
Email: NHLBI_@[email protected]

Financial/Grants Management Contact(s)

Ms. Ann Marie Brasile Mejac, AA,CRA
National Heart, Lung, and Blood Institute (NHLBI)
Phone: 301-827-8016
Email: [email protected]

Ms. Leslie West-Bushby
National Heart, Lung, and Blood Institute (NHLBI)
Phone: 301-827-8063
Email: [email protected]